426 related articles for article (PubMed ID: 18341423)
1. Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's disease.
Solomon B
Rejuvenation Res; 2008 Apr; 11(2):349-57. PubMed ID: 18341423
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for Alzheimer's disease.
Solomon B; Frenkel D
Neuropharmacology; 2010; 59(4-5):303-9. PubMed ID: 20388523
[TBL] [Abstract][Full Text] [Related]
3. Amyloid beta peptide immunotherapy in Alzheimer disease.
Delrieu J; Ousset PJ; Voisin T; Vellas B
Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
[TBL] [Abstract][Full Text] [Related]
5. Beta-amyloidbased immunotherapy as a treatment of Alzheimers disease.
Solomon B
Drugs Today (Barc); 2007 May; 43(5):333-42. PubMed ID: 17724499
[TBL] [Abstract][Full Text] [Related]
6. [Current trend of immunotherapy for Alzheimer's disease].
Matsumoto SE; Tabira T
Nihon Rinsho; 2011 Sep; 69(9):1628-32. PubMed ID: 21922765
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy against amyloid pathology in Alzheimer's disease.
Galimberti D; Ghezzi L; Scarpini E
J Neurol Sci; 2013 Oct; 333(1-2):50-4. PubMed ID: 23299047
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of A beta plaque clearance following passive A beta immunization.
Morgan D
Neurodegener Dis; 2005; 2(5):261-6. PubMed ID: 16909007
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapeutic strategies for prevention and treatment of Alzheimer's disease.
Solomon B
DNA Cell Biol; 2001 Nov; 20(11):697-703. PubMed ID: 11788047
[TBL] [Abstract][Full Text] [Related]
11. Clinical immunologic approaches for the treatment of Alzheimer's disease.
Solomon B
Expert Opin Investig Drugs; 2007 Jun; 16(6):819-28. PubMed ID: 17501694
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and immunotherapy.
Solomon B
Curr Alzheimer Res; 2004 Aug; 1(3):149-63. PubMed ID: 15975063
[TBL] [Abstract][Full Text] [Related]
13. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
Vasilevko V; Cribbs DH
Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
Carter CJ
Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
[TBL] [Abstract][Full Text] [Related]
15. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease.
Nicoll JAR; Buckland GR; Harrison CH; Page A; Harris S; Love S; Neal JW; Holmes C; Boche D
Brain; 2019 Jul; 142(7):2113-2126. PubMed ID: 31157360
[TBL] [Abstract][Full Text] [Related]
16. Immunological approaches as therapy for Alzheimer's disease.
Solomon B
Expert Opin Biol Ther; 2002 Dec; 2(8):907-17. PubMed ID: 12517269
[TBL] [Abstract][Full Text] [Related]
17. Antibody against C-terminal Abeta selectively elevates plasma Abeta.
Gray AJ; Sakaguchi G; Shiratori C; Becker AG; LaFrancois J; Aisen PS; Duff K; Matsuoka Y
Neuroreport; 2007 Feb; 18(3):293-6. PubMed ID: 17314674
[TBL] [Abstract][Full Text] [Related]
18. A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice.
Demattos RB; Lu J; Tang Y; Racke MM; Delong CA; Tzaferis JA; Hole JT; Forster BM; McDonnell PC; Liu F; Kinley RD; Jordan WH; Hutton ML
Neuron; 2012 Dec; 76(5):908-20. PubMed ID: 23217740
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for Alzheimer's disease.
Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy as treatment for Alzheimer's disease.
Hawkes CA; McLaurin J
Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
